Bayer AG (XSWX:BAYN) Cash Flow from Investing: CHF-1,877 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BAYN Bayer AG XSWX:BAYN
51 GF Score
Price CHF45.85
GF Value CHF24.56
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bayer AG Cash Flow from Investing?

Bayer AG XSWX:BAYN 51 Cash Flow from Investing is CHF-1,877 Mil as of Jun. 2026. GuruFocus rates XSWX:BAYN with a GF Score™ of 51/100 and a GF Value™ of CHF24.56 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Jun. 2026, Bayer AG spent CHF608 Mil on purchasing property, plant, equipment. It gained CHF41 Mil from selling property, plant, and equipment. It spent CHF272 Mil on purchasing business. It gained CHF0 Mil from selling business. It spent CHF38 Mil on purchasing investments. It gained CHF163 Mil from selling investments. It paid CHF0Mil for net Intangibles purchase and sale. And it received CHF63 Mil from other investing activities. In all, Bayer AG spent CHF651 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Jun. 2026.


Bayer AG  (XSWX:BAYN) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Bayer AG's purchase of property, plant, equipment for the three months ended in Jun. 2026 was CHF-608 Mil. It means Bayer AG spent CHF608 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Bayer AG's sale of property, plant, equipment for the three months ended in Jun. 2026 was CHF41 Mil. It means Bayer AG gained CHF41 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Bayer AG's purchase of business for the three months ended in Jun. 2026 was CHF-272 Mil. It means Bayer AG spent CHF272 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Bayer AG's sale of business for the three months ended in Jun. 2026 was CHF0 Mil. It means Bayer AG gained CHF0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Bayer AG's purchase of investment for the three months ended in Jun. 2026 was CHF-38 Mil. It means Bayer AG spent {stock_data.stock.currency_symbol}}38 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Bayer AG's sale of investment for the three months ended in Jun. 2026 was CHF163 Mil. It means Bayer AG gained CHF163 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Bayer AG's net Intangibles purchase and sale for the three months ended in Jun. 2026 was CHF0 Mil. It means Bayer AG paid CHF0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Bayer AG's cash from discontinued investing activities for the three months ended in Jun. 2026 was 0 Mil. It means Bayer AG paid CHF0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Bayer AG's cash from other investing activities for the three months ended in Jun. 2026 was CHF63 Mil. It means Bayer AG received CHF63 Mil from other investing activities.


Bayer AG Cash Flow from Investing Related Terms


Bayer AG Cash Flow from Investing Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cash Flow from Investing Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 889.78 -2,349.72 -3,316.80 153.11 -1,185.09

Bayer AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.44 -996.99 -483.37 254.85 -651.04
XSWX:BAYN
51GF Score
Bayer AG XSWX:BAYN
Cash Flow from Investing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Bayer AG's Cash Flow from Investing for the fiscal year that ended in Dec. 2025 is calculated as:

Bayer AG's Cash Flow from Investing for the quarter that ended in Jun. 2026 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-1,877 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Investing of CHF-1,877 Mil mean?
Bayer AG (XSWX:BAYN) has a Cash Flow from Investing of CHF-1,877 Mil as of Jun. 2026. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Bayer AG and its competitors.
Is Bayer AG's Cash Flow from Investing too high?
Bayer AG's current Cash Flow from Investing is CHF-1,877 Mil. Overall, Bayer AG has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Cash Flow from Investing compare to LLY and JNJ?
Bayer AG's Cash Flow from Investing of CHF-1,877 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Investing for a Drug Manufacturers company?
A good Cash Flow from Investing depends on the Drug Manufacturers industry context. However, Cash Flow from Investing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Investing mean?
A high Cash Flow from Investing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Bayer AG and its competitors. Bayer AG's current Cash Flow from Investing is CHF-1,877 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (XSWX:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF24.56, compared to a current price of CHF45.85 — trading 86.7% above its estimated fair value. The current Cash Flow from Investing is CHF-1,877 Mil. Bayer AG's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Investing calculated?
Cash Flow from Investing is calculated from a company's financial statements. For Bayer AG (XSWX:BAYN), the current Cash Flow from Investing is CHF-1,877 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (XSWX:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of CHF45.85 is trading 86.7% above its estimated GF Value™ of CHF24.56. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for XSWX:BAYN:

  • Cash Flow from Investing: CHF-1,877 Mil
  • GF Value™: CHF24.56 vs. price of CHF45.85 (86.7% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
51GF Score

Get the complete analysis for XSWX:BAYN

Cash Flow from Investing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF45.85
Price
CHF24.56
GF Value